Porcine epidemic diarrhea virus g2b subtype strain and application thereof
By isolating and purifying the porcine epidemic diarrhea virus G2b subtype strain GZ2504, an inactivated vaccine and ELISA kit were prepared, solving the problem of low virus titer, achieving efficient virus control and diagnosis, and reducing economic losses.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHINA ANIMAL HUSBANDRY IND
- Filing Date
- 2026-02-10
- Publication Date
- 2026-05-29
AI Technical Summary
Existing technologies are insufficient for effectively isolating and culturing porcine epidemic diarrhea virus G2b subtype strains, resulting in low viral titers and a lack of highly effective vaccines and diagnostic reagents, leading to economic losses for the livestock industry.
A porcine epidemic diarrhea virus (PEDV) G2b subtype strain, GZ2504, was isolated and purified, and a corresponding inactivated vaccine and ELISA kit were prepared. Utilizing the high proliferation rate and titer of this strain on Vero cells, the prepared vaccine was able to induce high levels of neutralizing antibodies, and the ELISA kit could detect the antibodies with sensitivity and specificity.
It provides an efficient method for virus propagation, the inactivated vaccine prepared has good immunogenicity, and the ELISA kit has high sensitivity and specificity, supporting effective virus control and diagnosis and reducing economic losses.
Smart Images

Figure FT_1 
Figure SMS_1 
Figure SMS_2